TY - JOUR
T1 - Effects of hydrochlorothiazide on oxidative stress and pulse pressure in hypertensive patients with chronic stroke
T2 - The EMINENT study
AU - EMINENT Study Investigators
AU - Nakane, Hiroshi
AU - Kamouchi, Masahiro
AU - Hata, Jun
AU - Ibayashi, Setsuro
AU - Kusuda, Kenji
AU - Omae, Tsuyoshi
AU - Nagao, Tetsuhiko
AU - Ago, Tetsuro
AU - Kitazono, Takanari
N1 - Publisher Copyright:
© 2015 The Japanese Society of Internal Medicine.
Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 2015
Y1 - 2015
N2 - Objective Thiazide diuretics are reported to have antioxidant effects and reduce pulse pressure (PP). The aim of this study was to elucidate whether hydrochlorothiazide additionally exerts such effects in stroke pa-tients under treatment with losartan. Methods This study was an open-label, randomized, multicenter study. Patients with a history of chronic stroke and treatment with angiotensin receptor blockers or angiotensin-converting enzyme inhibitors for es-sential hypertension were enrolled. Fifty-five hypertensive patients were randomly assigned to two groups: those further treated with hydrochlorothiazide and those further treated with non-diuretic antihypertensive drugs. Results Both groups showed a significant decrease in PP over six months (hydrochlorothiazide group: 67± 12 mmHg to 58±12, p<0.001; non-diuretic group: 72±12 to 61±12, p<0.001), although no significant differ-ences were observed between the two groups. The malondialdehyde-modified low-density lipoprotein levels did not change significantly after treatment in either group. Conclusion In this study, hydrochlorothiazide treatment did not provide any additional benefits over non-diuretic antihypertensive drugs in terms of antioxidant effects or reducing PP.
AB - Objective Thiazide diuretics are reported to have antioxidant effects and reduce pulse pressure (PP). The aim of this study was to elucidate whether hydrochlorothiazide additionally exerts such effects in stroke pa-tients under treatment with losartan. Methods This study was an open-label, randomized, multicenter study. Patients with a history of chronic stroke and treatment with angiotensin receptor blockers or angiotensin-converting enzyme inhibitors for es-sential hypertension were enrolled. Fifty-five hypertensive patients were randomly assigned to two groups: those further treated with hydrochlorothiazide and those further treated with non-diuretic antihypertensive drugs. Results Both groups showed a significant decrease in PP over six months (hydrochlorothiazide group: 67± 12 mmHg to 58±12, p<0.001; non-diuretic group: 72±12 to 61±12, p<0.001), although no significant differ-ences were observed between the two groups. The malondialdehyde-modified low-density lipoprotein levels did not change significantly after treatment in either group. Conclusion In this study, hydrochlorothiazide treatment did not provide any additional benefits over non-diuretic antihypertensive drugs in terms of antioxidant effects or reducing PP.
UR - http://www.scopus.com/inward/record.url?scp=84926654680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926654680&partnerID=8YFLogxK
U2 - 10.2169/internalmedicine.54.2631
DO - 10.2169/internalmedicine.54.2631
M3 - Article
C2 - 25790807
AN - SCOPUS:84926654680
SN - 0918-2918
VL - 54
SP - 573
EP - 577
JO - Internal Medicine
JF - Internal Medicine
IS - 6
ER -